USANA Health Sciences (USNA) Tops Q1 EPS by 12c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

Go back to USANA Health Sciences (USNA) Tops Q1 EPS by 12c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

Pivotal Research Downgrades USANA Health Sciences Inc. (USNA) to Hold Citing Valuation

April 23, 2018 10:08 AM EDT

Pivotal Research downgraded USANA Health Sciences Inc. (NYSE: USNA) from Buy to Hold with a price target of $95.00.

For an analyst ratings summary and ratings history on USANA Health Sciences Inc.... More